Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2020 Publisher: The Wellcome Foundation Ltd, 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom Trading as: GlaxoSmithKline UK
Daraprim 25 mg Tablets.
| Pharmaceutical Form |
|---|
|
Tablet. Each tablet is white and round with the marking GS A3A. |
Each tablet contains 25 mg of pyrimethamine.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Pyrimethamine |
Pyrimethamine is an antiparasitic agent. The antiparasitic action of pyrimethamine is due to its specific activity on folic acid metabolism in the Plasmodium and Toxoplasma parasites. |
| List of Excipients |
|---|
|
Lactose monohydrate |
PVC/PVdC/aluminium foil blister pack or PVC/PVdC/child-resistant aluminium foil blister pack.
Pack size: 30 tablets.
The Wellcome Foundation Ltd, 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom
Trading as: GlaxoSmithKline UK
PL 00003/5026R
Date of first authorisation: 25 September 1986
Date of latest renewal: 19 February 2011
| Drug | Countries | |
|---|---|---|
| DARAPRIM | Brazil, Estonia, Spain, Malta, Mexico, Netherlands, United Kingdom, United States |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
